4RD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Maat Pharma SA

Watchlist Manager

Watchlist

Price: 2.69 EUR -0.92% Market Closed

Market Cap: €37.4m

M	Maat Pharma SA F:4RD	FR
	Ibiden Co Ltd F:IBI	JP
C	Companhia Energetica de Minas Gerais CEMIG F:CID	BR
	Made Tech Group PLC F:5UH	UK
N	Northland Power Inc OTC:NPIFF	CA
A	adesso SE XMUN:ADN1	DE
	Kore Potash PLC F:KP10	UK
B	Bravura Solutions Ltd OTC:BVSFF	AU
	Innate Pharma SA F:IDDA	FR
	Kore Potash PLC F:KP1	UK
R	Royal Gold Inc XMUN:RG3	US
	STRABAG SE VSE:STR	AT
P	Pola Orbis Holdings Inc F:8PO	JP
M	Molson Coors Canada Inc F:65K	CA
G	Graphisoft Park SE Ingatlanfejleszto Europai Rt F:GUV	HU
	Shimizu Corp F:XSZ	JP
	Molten Ventures PLC F:GRW	UK

Profitability Summary

Maat Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

68%

Declining Gross Margin

76% > 69%

Negative Operating Margin

-657%

Negative 3Y Average Operating Margin

-800%

Operating Margin is Increasing

-948% > -657%

Negative Net Margin

-687%

Negative 3Y Average Net Margin

-808%

Net Margin is Increasing

-959% > -687%

Negative Free Cash Flow Margin

-361%

Negative 3Y Average Free Cash Flow Margin

-702%

Free Cash Flow Margin is Increasing

-928% > -361%

Negative ROE

-512%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-236%

Declining ROIC

-317% > -345%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.